-
Symbol
-
MAZE on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001
-
Latest Disclosed Ownership
-
3.35M shares
-
Security Ownership
-
7.7%
Frazier Life Sciences Public Fund, L.P. ownership in Maze Therapeutics, Inc. Common Stock, par value $0.001 (MAZE)
2025-08-14 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.35M shares of Maze Therapeutics, Inc. Common Stock, par value $0.001 (MAZE).
This represents 7.7% percent ownership of the company.
In their previous filing dated 2025-04-29, Frazier Life Sciences Public Fund, L.P. had reported owning 4.45M shares, indicating a decrease of -24.7% percent.